Gelder Mark S. MD 4
4 · AP PHARMA INC /DE/ · Filed Feb 12, 2013
Insider Transaction Report
Form 4
Gelder Mark S. MD
SVP & Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2013-02-08+75,000→ 75,000 totalExercise: $0.75Exp: 2023-02-08→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Grant vests monthly over a 4 year period and will fully vest on February 8, 2017.